CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 312 enrolled
Drug / intervention
Text Message +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05236270
NCT05236270N/ACompleted
CompareCT.gov

CATCH-UP Vaccines: Extension of Community - Engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations

University of Oklahoma·interventional·Posted Feb 11, 2022·Updated May 22, 2024

In Brief

A clinical study evaluating Text Message, Motivational Interviewing, and 1 other intervention for COVID-19 and Vaccine Refusal. Completed, enrolled 312 participants across 1 site.

Detailed Summary

Oklahoma has high COVID-19 incidence, particularly among underserved minority and rural Oklahomans. Oklahoman's are also reporting SARS-CoV-2 vaccine hesitancy and signs of slowing vaccine uptake, with increased hesitancy among American Indian and rural populations. The project aims to work with ongoing community testing events to implement interventions to improve vaccine uptake among Oklahoma's underserved populations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19, Vaccine Refusal
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS)

Timeline

N/ACompletedFinished
20222023202420252026
First PostedFeb 11, 2022
Enrollment StartMar 25, 2022
Primary CompletionJun 28, 2023
Study CompletionAug 26, 2023
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 4.4 years ago

Interventions

Text Messagebehavioral

Participants will be randomized to receive or not receive a text message encouraging COVID-19 vaccine uptake.

Motivational Interviewingbehavioral

Participants will be randomized to receive either motivational interviewing when receiving SARS-CoV-2 antibody test results or standard interpretation of antibody results.

Electronic Educational Message with Tailored Questions/Promptsbehavioral

Participants will be randomized to receive either an electronic educational message tailored to their COVID-19 vaccine concerns and vaccine status or an attention control message about overall healthy choices.